RE:Stock PriceMy 5 cents: there is wide-spread doubt in telehealth stocks as world comes out of COVID. The big players results sucked recently so the narrative from CEO's vs. actual performance isnt inspiring confidence. Until the sector starts reporting string results, the market will stay skeptical imho.
DOC: Dr Hamza has said its not a COVID stock. In his Q4 statement, he said they expect perfromance to accelarate as things come out of COVID/Pandemic status.
DOC is at around 270MM shares after all raise/acquisitions complete so I dont expect it to do anything amazing until its shows solid upside performance. We have Q1 at end of May and they said they are moving to Uplist in June/Summer time.
Cannacord Genuity 2 weeks back, following the Laurentian Bank Investor conference reaffirmed their TP of $3.50/share which factored recent news and 270MM shares etc.
My hunch is, it will be end of Q2 before things start radically changing upward....unless they announce more news ie Enterprise deals, Provence expansion etc.